RADXRadiopharm Theranostics Limited
2.290USDMkt Cap: 18.05M $P/E:

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical nee…

Key Statistics

Company
Market Cap18.05M $
Enterprise Value-9.30M $
Revenue (TTM)16.28M $
Gross Profit39.28K $
Net Income (TTM)-38.34M $
Revenue/Share2.100 USD
Last Price2.290 USD
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-1.00
PEG
EV/EBITDA0.24
EV/Revenue-0.57
P/S1.11
P/B0.72
EPS (TTM)-3.75
EPS (Forward)-2.30
52W Range
2.23027% of range2.450
52W High2.450 USD
52W Low2.230 USD
Profitability
Gross Margin1.08%
Oper. Margin-423.75%
EBITDA Margin-240.69%
Profit Margin-1055.27%
ROE-85.60%
ROA-44.34%
Growth
Revenue Growth154.50%
Earnings Growth
Cash Flow & Leverage
Operating CF-37.10M $
CapEx (TTM)
FCF Margin-128.23%
FCF Yield-115.63%
Net Debt-34.52M $
Net Debt/EBITDA0.88
Balance Sheet
Debt/Equity
Current Ratio3.01
Quick Ratio3.00
Book Value/Sh3.179 USD
Cash/Share2.922 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)17.38 USD
Upside (mean)+658.9%
Target Range12.73 USD30.71 USD
$12.73+658.9% to mean$30.71
# Analysts6
Ownership
Shares Out.7.88M
Float9.08M
Insiders0.00%
Institutions0.81%
Short Interest
Short Ratio0.6d
Short % Float1.18%
Short % Out.0.94%
Shares Short74.10K
Short (prev mo.)62.57K
Technical
SMA 503.786 (-39.5%)
SMA 2004.533 (-49.5%)
Beta0.77
S&P 52W Chg21.00%
Avg Vol (30d)88.86K
Avg Vol (10d)45.62K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)